European Urology Publishes Results of SmartTarget Biopsy Trial
The recent issue of European Urology featured the article “The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing...
The recent issue of European Urology featured the article “The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing...
SmartTarget Ltd, a spinout of UCL (University College London) that has developed a CE-approved device for precision prostate biopsy and...
SmartTarget is sponsoring the latest MRI Masterclass in prostate cancer for urologists at UCL Life Learning. This short course run by...
We are currently looking to recruit urological nurses to receive specialist training for supporting SmartTarget use in theatre for our...
London, 30th September 2016 SmartTarget Ltd announces the launch of its new device for the detection of prostate cancer. The...
SmartTarget Ltd are pleased to announce their CE-marked device for transperineal fusion biopsy will be formally launched as a market-ready...